| Name | Title | Contact Details |
|---|---|---|
Maxwell Larimer |
Chief Technology Officer | Profile |
GreyNoise analyzes Internet background noise. Use GreyNoise to remove pointless security alerts, find compromised devices, or identify emerging threats.
Vela is a leading independent provider of trading and market access technology for global multi-asset electronic trading. Our software enables clients to successfully execute on their trading strategies and manage risk across multiple fragmented markets, liquidity pools, and data sources. We help firms successfully differentiate and innovate in an ever-changing, increasingly-regulated and fiercely-competitive landscape, while also reducing total cost of ownership. Velas ticker plant, execution gateways, trading platform, and risk and analytics software deliver a unique, ultra-low latency technology stack for electronic low-touch and Direct Market Access (DMA) execution and pricing. We leverage the latest innovations in technology to deliver cutting-edge performance, features and reliability. Our modular stack is accessed through a single set of trading, data and risk APIs and can be delivered as-a-Service from multiple co-location data centers globally. With access to more than 250 venues, Vela provides global coverage across all major asset classes. Clients are supported by an award-winning team of technical and business experts available 24x7 from our multiple offices in the US, Europe, and Asia. Velas clients include traders, market makers, brokers, banks, investment firms, exchanges, and other market participants.
Banjo brings the power of location-based social event detection to newsrooms, big brands and financial professionals looking for a competitive advantage. Banjo`s detection engine has the advanced technology and real time capability to filter billions of data points by location, time and context, allowing access to events the instant they happen, anytime, anywhere.
Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.
Summit Technologies provides Cyber Security, Knowledge Management, Web & Software, and IT Services for the Federal Government and Fortune 1,000 companies.